SGTX
Sigilon Therapeutics, Inc.
Price:  
22.47 
USD
Volume:  
81,878.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SGTX WACC - Weighted Average Cost of Capital

The WACC of Sigilon Therapeutics, Inc. (SGTX) is 7.4%.

The Cost of Equity of Sigilon Therapeutics, Inc. (SGTX) is 7.95%.
The Cost of Debt of Sigilon Therapeutics, Inc. (SGTX) is 8.00%.

Range Selected
Cost of equity 6.80% - 9.10% 7.95%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 9.00% 8.00%
WACC 6.4% - 8.4% 7.4%
WACC

SGTX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.63 0.75
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 9.10%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.33 0.33
Cost of debt 7.00% 9.00%
After-tax WACC 6.4% 8.4%
Selected WACC 7.4%